TNKase: Update

An international, 6,000-patient Phase IIIb ASSENT 3 study will evaluate TNKase with heparin, Lovenox enoxaparin low molecular weight heparin from Aventis S.A.

Read the full 228 word article

How to gain access

Continue reading with a
two-week free trial.